Development of novel HBV vaccines to overcome nonresponsiveness and studies of immunopathogenic mechanisms of chronic HBV and HBV-associated hepatocellular carcinoma
博士 === 國立臺灣大學 === 微生物學研究所 === 99 === Hepatitis B virus (HBV) infection remains one of the most important infectious diseases for human. More than a third of the world''s population has been infected with HBV and more than 350 million are chronic carriers, of whom 15-40% is at risk...
Main Authors: | Ho-Yuan Chou, 周和源 |
---|---|
Other Authors: | 陶秘華 |
Format: | Others |
Language: | en_US |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/97211206718959851251 |
Similar Items
-
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
by: Jiang Y, et al.
Published: (2021-05-01) -
Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021-08-01) -
Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
by: Joseph Yoo, et al.
Published: (2018-04-01) -
Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
by: Huang De-Rong, et al.
Published: (2010-11-01) -
HBV Pre-S Mutant-mediated Molecular Events in Precursor Lesions of HBV-related Hepatocellular Carcinoma
by: Jui-ChuYang, et al.
Published: (2010)